New study rebuts the claim that antidepressants do not work

August 18, 2017
Antidepressant
Fluoxetine (Prozac). Image: Wikimedia Commons

A theory that has gained considerable attention in international media, including Newsweek and the CBS broadcast 60 minutes, suggests that antidepressant drugs such as the SSRIs do not exert any actual antidepressant effect. A research group at the Sahlgrenska Academy has now analyzed data from clinical trials and can rebut this theory.

According to the challenged hypothesis, the fact that many people medicating with antidepressants regard themselves as improved may be attributed to a effect, i.e. that someone who expects to be improved by a medication often also feels improved, even if the medicine lacks actual effect.

However, if SSRIs had, indeed, acted merely by means of a placebo effect, these drugs should not outperform actual placebo in clinical trials where patients have been treated with an SSRI or with ineffective placebo pills, and where neither the physician nor the patient knows which treatment the patient has been given until the study is over.

To explain why antidepressants in such trials nevertheless often cause greater symptom relief than placebo, it has been suggested that SSRI-induced side effects will make the patient understand that he or she has not been given placebo, hence enhancing his or her belief of having been given an effective treatment.

The beneficial effect of SSRIs that has been shown in many studies should thus, according to this theory, not be due to the fact that these drugs exert a specific biochemical antidepressant action in the brain, but that the side effects of the drugs enhance a psychological .

This theory has been widely disseminated despite the fact that there has never been any robust scientific support for it. Thus, so far, it has never been investigated whether individuals in clinical trials experiencing side effects from antidepressant medication, and for this reason may have guessed that they have not received placebo, also respond more favorably to treatment than those without side effects.

In order to examine the "placebo breaking the blind" theory, a research group at the Sahlgrenska Academy in Gothenburg, Sweden, has now analyzed data from the clinical trials that were once undertaken to establish the antidepressant efficacy of two of the most commonly used SSRIs, paroxetine and citalopram.

The analysis, which comprised a total of 3 344 patients, shows that the two studied drugs are clearly superior to placebo with respect to antidepressant efficacy also in patients who have not experienced any side effects. The theory that antidepressants outperform placebo merely by means of side effects making the patient aware that they have not received placebo, and enhancing the expectancy of improvement, may hence be rejected.

The researchers conclude that this study, as well as other recent reports from the same group, provides strong support for the assumption that SSRIs exert a specific antidepressant effect. They suggest that the frequent questioning of these drugs in media is unjustified and may make depressed patients refrain from effective treatment.

Explore further: Are antidepressants more effective than usually assumed?

More information: F Hieronymus et al. Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression, Molecular Psychiatry (2017). DOI: 10.1038/mp.2017.147

Related Stories

Are antidepressants more effective than usually assumed?

May 27, 2015
Many have recently questioned the efficacy of the most common antidepressant medications, the selective serotonin reuptake inhibitors (SSRIs). The conclusion that these drugs are ineffective is however partly based on a misinterpretation ...

Placebo effective despite intellectual disability

May 17, 2017
Contrary to earlier beliefs, people with severe congenital intellectual disability are sensitive to placebo-like effects, new research from Karolinska Institutet shows, published in the scientific journal Neurology. The results ...

Antidepressant efficacy varies for depressive symptom clusters

February 28, 2017
(HealthDay)—Antidepressant treatment efficacy varies for empirically-defined clusters of symptoms, according to a study published online Feb. 22 in JAMA Psychiatry.

Antidepressants may be no better than a placebo, so why take them?

October 29, 2014
Seventeenth-century Oxford scholar Robert Burton's lifework, The Anatomy of Melancholy, weighs in at a door-stopping 1,400 pages. But his cure for the "Black Choler" of depression came down to just six words: "Be not solitary, ...

Antidepressants boost CBT for social anxiety

July 5, 2016
Treatments for social anxiety disorder often include either selective serotonin reuptake inhibitors (SSRIs) or cognitive behavioural therapy (CBT), but new research from Uppsala University indicates that social anxiety disorder ...

Common antidepressant increased coronary atherosclerosis in animal model

April 6, 2015
A commonly prescribed antidepressant caused up to a six-fold increase in atherosclerosis plaque in the coronary arteries of non-human primates, according to a study by researchers at Wake Forest Baptist Medical Center. Coronary ...

Recommended for you

How the shape and size of your face relates to your sexuality

September 19, 2017
Men and women with shorter, wider faces tend to be more sexually motivated and to have a stronger sex drive than those with faces of other dimensions. These are the findings from a study led by Steven Arnocky of Nipissing ...

Behavioral therapy increases connectivity in brains of people with OCD

September 19, 2017
UCLA researchers report that people with obsessive-compulsive disorder, when treated with a special form of talk therapy, demonstrate distinct changes in their brains as well as improvement in their symptoms.

Cognitive scientists find that people can more easily communicate warmer colors than cool ones

September 18, 2017
The human eye can perceive millions of different colors, but the number of categories human languages use to group those colors is much smaller. Some languages use as few as three color categories (words corresponding to ...

Why bad sleep doesn't always lead to depression

September 18, 2017
Poor sleep is both a risk factor, and a common symptom, of depression. But not everyone who tosses and turns at night becomes depressed.

Happiness is not determined by childhood biomarkers

September 18, 2017
Happiness is not determined by childhood biological markers such as height or body fat, according to a team of European researchers involving UCL.

People with schizophrenia have threefold risk of dying

September 18, 2017
People with schizophrenia are three times more likely to die, and die younger, than the general population, indicating a need for solutions to narrow this gap, according to research published in CMAJ (Canadian Medical Association ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.